NCT00162435View on ClinicalTrials.gov

Genetic Determinants of Warfarin Anticoagulation Effect

NAUnknownINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Venous ThrombosisPulmonary EmbolismAtrial Fibrillation
Interventions
DRUG

Warfarin

Trial Locations (1)

Unknown

RECRUITING

Hadassah Medical Organization, Jerusalem

Sponsors

Collaborators (1)

Israel Science Foundation
All Listed Sponsors
collaborator

United States - Israel Binational Science Foundation

OTHER

collaborator

Israel Science Foundation

OTHER

collaborator

Ministry of Health, Israel

OTHER_GOV

lead

Hadassah Medical Organization

OTHER